Site Identification & Feasibility logo

Site Identification & Feasibility

Clinical trial site selection using IRB-backed performance data and streamlined feasibility assessments for sponsors and CROs.

Solution by Advarra
Visit website

Overview

Advarra's Site Identification & Feasibility solution is designed to help sponsors and CROs modernize the way they select and qualify clinical trial sites. By leveraging intelligence drawn from Advarra's industry-leading IRB and a rich operational dataset, the platform moves beyond self-reported feasibility data to reveal how sites actually perform in practice — enabling faster, more confident site selection decisions.

The solution serves sponsors and CROs seeking to reduce trial startup timelines, improve enrollment predictability, and ensure that selected sites meet quality and compliance standards before a study begins. It combines evidence-based site intelligence with integrated feasibility assessment tools, allowing teams to identify high-potential sites and move directly into qualification without switching platforms.

IRB-Backed Site Intelligence

  • Access objective performance signals including enrollment productivity, timeline adherence, and reliability to compare targets against actual delivery across real trials.
  • Assess site responsiveness, turnaround times, and protocol deviation trends to evaluate quality and compliance prior to selection.
  • Use evidence-based enrollment forecasts grounded in historical performance and operational patterns rather than assumptions, strengthening enrollment planning.
  • Go beyond self-reported feasibility to understand how sites truly operate, informed by Advarra's IRB data and operational insights.

Site Intelligence Footprint

  • Site intelligence is curated across four categories: experience and profile, capacity, performance, and quality.
  • The dataset spans more than 30,000 studies, 150,000+ principal investigators, and 25,000+ research institutions.

Integrated Feasibility Assessment Capabilities

  • Reduce redundant requests on sites: Centralize the collection of site responses and monitor progress in one place, eliminating the need to chase status updates or re-request previously submitted documents. Responses can be leveraged across multiple studies to respect sites' time.
  • Feasibility scoring: Quickly identify the best site partners using a feasibility score informed by responses to each individual survey question.
  • Real-time forecasting: Monitor response rates and forecast a group of sites' enrollment potential to expedite site selection and activation milestones.
  • Rapid survey deployment: Identify and organize potential site partners via individual entry or by uploading an Excel file. Each survey field is fully customizable once sites are imported.
  • Response monitoring: Gain detailed visibility into the feasibility process by tracking which sites have been invited, which are currently reviewing the survey, and which have made progress on completion.

Workflow Benefits

  • Move seamlessly from site identification into qualification through integrated shortcuts, reducing delays between discovery and activation.
  • Prioritize high-performing, compliant sites earlier in the process to reduce the risk of timeline and budget overruns.
  • Support teams conducting high volumes of feasibility assessments — as demonstrated by Velocity Clinical Research, which reported conducting more than thirty feasibilities in a single day using Advarra's technology solutions.

Advarra's Site Identification & Feasibility solution is positioned as part of a broader suite of clinical trial technology offerings, with the platform designed to integrate site intelligence and feasibility workflows into a unified experience for sponsors, CROs, and research networks operating at scale.

Meta

Domain
Clinical Trial Management
Subdomain
Clinical Trial Management Systems (CTMS) & eTMF
Software type(s)
Analytical Platform
Deployment type(s)
Cloud / SaaS
Industry vertical(s)
Academic / ResearchBiotechCROPharma
Development stage(s)
Clinical
Target user(s)
Research ScientistQA / Regulatory AffairsClinical / Diagnostic Professional
Compliance standard(s)
GxP